Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for cancer immunotherapy

Compositions and methods for cancer immunotherapy

US Patent 6310045 · Granted Oct 30, 2001

Estimated economic value: $108,216,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant vectors comprising 2A peptide2022
Retroviral vector having immune-stimulating activity2022
Formulations of 5-fluorocytosine and uses thereof2021
Retroviral vector with mini-promoter cassette2021
Producer cells for replication competent retroviral vectors2021
Formulations of 5-fluorocytosine and uses thereof2019
Recombinant vectors2019
Producer cells for replication competent retroviral vectors2019
Gene therapy vectors and cytosine deaminases2018
Formulations of 5-fluorocytosine and uses thereof2018
Recombinant vectors2017
Compositions comprising gamma retrovirus vectors and methods of treating prolife2017